prgn-3006
pgen therapeutics
['leukemia', 'myeloid', 'prgn-3006', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', '$pgen']
about time, $pgen released their #ash22 data pr&gt; single infusion of autologous prgn-3006 cells resulted in 27% objective response rate (orr) in heavily pre-treated r/r) acute myeloid leukemia (aml) patients infused following lymphodepletion 
Long term biotech investor/trader; healthcare field; tend to hold a few names long term; follow at your own risk {Not advice} Do your own due diligence! b4 buy.